Citation Impact
Citing Papers
Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS
2014
Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease
2012
Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion
2014
Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria
2013
The role of bile acids in functional GI disorders
2014
Colonic bacterial composition in Parkinson's disease
2015 Standout
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Bile acid transporters and regulatory nuclear receptors in the liver and beyond
2012
Intestinal barrier: A gentlemen’s agreement between microbiota and immunity
2014
Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome
2011
A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea
2011
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome
2009
Serotonin in the gastrointestinal tract
2009
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Bowel Disorders
2016 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Intestinal barrier function in health and gastrointestinal disease
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Lessons learned — resolving the enigma of genetic factors in IBS
2016
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
2011
Genetic Approaches to Functional Gastrointestinal Disorders
2010
Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis
2011
Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases
2017
The Gut Barrier
2012
Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome with Diarrhea
2012
Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea
2012
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
2011
Methods to determine intestinal permeability and bacterial translocation during liver disease
2015
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)
2011
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Irritable bowel syndrome
2016 Standout
Watersheds in Child Mortality: The Role of Effective Water and Sewerage Infrastructure, 1880–1920
2018 StandoutNobel
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Confocal Endomicroscopy Shows Food-Associated Changes in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
2010
Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders
2011
Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren
2021
Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
2011
Peripheral Mechanisms in Irritable Bowel Syndrome
2012
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
2009
Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: A randomized controlled crossover trial
2012
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Intestinal Permeability Defects: Is It Time to Treat?
2013
The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis
2017
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis
2014
Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome
2009
Advances in understanding of bile acid diarrhea
2013
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Clinical Guideline: Management of Gastroparesis
2012
A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
2011
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis
2013
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
2016
Environmental enteropathy: critical implications of a poorly understood condition
2012
Cannabinoids and the gut: New developments and emerging concepts
2010
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
2014
Leaky gut – concept or clinical entity?
2016
Irritable bowel syndrome: towards biomarker identification
2009
Irritable Bowel Syndrome
2015 Standout
Methylnaltrexone for the treatment of opioid-induced constipation
2012
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
2012
Microflora Modulation of Motility
2011
Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity
2014
Recent advances in the development of farnesoid X receptor agonists.
2015
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
2012
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome
2014
A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function
2013
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
2015
Natural product and natural product derived drugs in clinical trials
2014 Standout
Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
2011
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Irritable bowel syndrome: an integrated explanatory model for clinical practice
2015
Microbiota transplantation restores normal fecal bile acid composition in recurrentClostridium difficileinfection
2013
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
2020 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of Michael Ryks being referenced
The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus
2013
Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome
2013
Dose-response effect of a β3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health
2008
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome‐diarrhea
2012
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome
2008
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation
2007
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
2010
Candidate genes and sensory functions in health and irritable bowel syndrome
2008
Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion
2009
An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions
2007
Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea
2014
Pharmacogenetics of low dose clonidine in irritable bowel syndrome
2009
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health
2010
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls
2011
A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans
2012
Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea
2012
NGM282, Variant of FGF19, is a Gastric and Colonic Prokinetic and Stimulates Bowel Function in Patients with Functional Constipation: Phase 1B, Two-Dose, Placebocontrolled Study
2017
W1333 Candidate Adrenergic, Gnβ3 and Serotonergic Polymorphisms, Endophenotype, Pharmacogenetics of Clonidine in Irritable Bowel Syndrome and Health
2008